PEG-co-PCL nanoparticles modified with MMP-2/9 activatable low molecular weight protamine for enhanced targeted glioblastoma therapy

Tumor imaging by means of proteolytic activation of cell-penetrating peptides

Tao Jiang, Emilia S. Olson, Quyen T. Nguyen et al. · Proceedings of the National Academy of Sciences · 2004 · 821 citations · Full text

Medicine, Molecular Biology, Oncology +17

Aptamer-functionalized PEG–PLGA nanoparticles for enhanced anti-glioma drug delivery

Jianwei Guo, Xiaoling Gao, Lina Su et al. · Biomaterials · 2011 · 570 citations

Pharmacy, Oncology, Pharmaceutics +14

Activatable cell penetrating peptides linked to nanoparticles as dual probes for in vivo fluorescence and MR imaging of proteases

Emilia S. Olson, Tao Jiang, Todd A. Aguilera et al. · Proceedings of the National Academy of Sciences · 2010 · 566 citations · Full text

Medicine, Bioengineering, Oncology +17

Cellular uptake mechanism and intracellular fate of hydrophobically modified glycol chitosan nanoparticles

Hae Yun Nam, Seok Min Kwon, Hyunjin Chung et al. · Journal of Controlled Release · 2009 · 559 citations

Pharmacy, Biochemistry, Cell Biology +16

Biodegradable poly(ε-caprolactone) nanoparticles for tumor-targeted delivery of tamoxifen

Jugminder S. Chawla, Mansoor M. Amiji · International Journal of Pharmaceutics · 2002 · 480 citations

Pharmacy, Oncology, Pharmaceutics +14